Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 2/2019

01-04-2019 | Short Communication

Immune Thrombocytopenia is Still the Commonest Diagnosis on Consultative Hematology

Authors: Ram V. Nampoothiri, Charanpreet Singh, Deepesh Lad, Gaurav Prakash, Alka Khadwal, Neelam Varma, Pankaj Malhotra

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 2/2019

Login to get access

Abstract

Thrombocytopenia is often a source of concern for physicians and patients alike and is one of the commonest reasons for a hematology consultation. Through this study, we wish to ascertain the different etiologies which should be kept in mind by a hematologist when a consultation for thrombocytopenia is sought. We assessed the etiology & clinical features of thrombocytopenia seen on consultative hematology calls for patients admitted in the general ward of a tertiary care hospital. 88/277 hematology consultations taken over a course of 2 months were for thrombocytopenia. The median age of these patients was 30 years, 62.5% were female, and median platelet of 40,500/µL (1000–112000). Mild, moderate & severe thrombocytopenia was seen in 6.8%, 27.3% and 65.9% respectively. 50% of patients had a primary hematological diagnosis. Immune thrombocytopenia (ITP) was the commonest diagnosis (38.6%). Bleeding manifestations were present in 48.9% patients with 20.5% having a major bleed. One third of hematology consultations in the general ward and emergency of a tertiary care hospital are for thrombocytopenia. Almost in half, the etiology of thrombocytopenia is related to a primary hematological disorder. This information should help in decision making of use of appropriate resources.
Literature
1.
go back to reference Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM (2011) The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139:271–278CrossRefPubMed Hui P, Cook DJ, Lim W, Fraser GA, Arnold DM (2011) The frequency and clinical significance of thrombocytopenia complicating critical illness: a systematic review. Chest 139:271–278CrossRefPubMed
2.
go back to reference Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J et al (2013) Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 144:1207–1215CrossRefPubMed Williamson DR, Albert M, Heels-Ansdell D, Arnold DM, Lauzier F, Zarychanski R, Crowther M, Warkentin TE, Dodek P, Cade J et al (2013) Thrombocytopenia in critically ill patients receiving thromboprophylaxis: frequency, risk factors, and outcomes. Chest 144:1207–1215CrossRefPubMed
3.
go back to reference Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330CrossRef Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M, Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on T, Haemostasis (2001) Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 86:1327–1330CrossRef
4.
go back to reference Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. JTH 3:692–694PubMed Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the S, Standardization Committee of the International Society on T, Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. JTH 3:692–694PubMed
5.
go back to reference Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion M, Immunohaematology Work G (2009) Recommendations for the transfusion of plasma and platelets. Blood Transf 7:132–150 Liumbruno G, Bennardello F, Lattanzio A, Piccoli P, Rossetti G, Italian Society of Transfusion M, Immunohaematology Work G (2009) Recommendations for the transfusion of plasma and platelets. Blood Transf 7:132–150
6.
go back to reference Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, Mumford AD, Stanworth SJ, Tinegate H, British Committee for Standards in H (2017) Guidelines for the use of platelet transfusions. Br J Haematol 176:365–394CrossRefPubMed Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, Mumford AD, Stanworth SJ, Tinegate H, British Committee for Standards in H (2017) Guidelines for the use of platelet transfusions. Br J Haematol 176:365–394CrossRefPubMed
7.
go back to reference Teo CP, Kueh YK (1989) Incidence of thrombocytopenia in an acute care hospital. Ann Acad Med Singap 18:379–381PubMed Teo CP, Kueh YK (1989) Incidence of thrombocytopenia in an acute care hospital. Ann Acad Med Singap 18:379–381PubMed
8.
go back to reference Fountain EM, Arepally GM (2017) Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis 43:429–436CrossRefPubMed Fountain EM, Arepally GM (2017) Etiology and complications of thrombocytopenia in hospitalized medical patients. J Thromb Thrombolysis 43:429–436CrossRefPubMed
9.
go back to reference Vaughan JL, Fourie J, Naidoo S, Subramony N, Wiggill T, Alli N (2015) Prevalence and causes of thrombocytopenia in an academic state-sector laboratory in Soweto, Johannesburg, South Africa. S Afr Med J 105:215–219CrossRefPubMed Vaughan JL, Fourie J, Naidoo S, Subramony N, Wiggill T, Alli N (2015) Prevalence and causes of thrombocytopenia in an academic state-sector laboratory in Soweto, Johannesburg, South Africa. S Afr Med J 105:215–219CrossRefPubMed
10.
go back to reference Boxer M (2012) Consultation for thrombocytopenia in hospitalized patients. Blood 120:4659 Boxer M (2012) Consultation for thrombocytopenia in hospitalized patients. Blood 120:4659
Metadata
Title
Immune Thrombocytopenia is Still the Commonest Diagnosis on Consultative Hematology
Authors
Ram V. Nampoothiri
Charanpreet Singh
Deepesh Lad
Gaurav Prakash
Alka Khadwal
Neelam Varma
Pankaj Malhotra
Publication date
01-04-2019
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 2/2019
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-018-1045-7

Other articles of this Issue 2/2019

Indian Journal of Hematology and Blood Transfusion 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine